Nuvation Bio (NUVB) News Today → Bible Shocker: Have You Seen Elon Musk’s Miracle? (From InvestorPlace) (Ad) Free NUVB Stock Alerts $3.32 -0.09 (-2.64%) (As of 05/17/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 19 at 3:32 AM | americanbankingnews.comNuvation Bio (NYSE:NUVB) Rating Reiterated by WedbushMay 18 at 1:47 AM | americanbankingnews.comNuvation Bio Inc. (NYSE:NUVB) to Post Q2 2024 Earnings of ($0.06) Per Share, Wedbush ForecastsMay 17 at 7:10 AM | marketbeat.comNuvation Bio Inc. (NYSE:NUVB) Forecasted to Earn Q2 2024 Earnings of ($0.06) Per ShareNuvation Bio Inc. (NYSE:NUVB - Free Report) - Investment analysts at Wedbush decreased their Q2 2024 EPS estimates for Nuvation Bio in a research note issued to investors on Tuesday, May 14th. Wedbush analyst D. Nierengarten now forecasts that the company will earn ($0.06) per share for the quartMay 15, 2024 | markets.businessinsider.comBuy Rating Justified by Nuvation Bio’s Promising Drug Prospects and Strong FinancialsMay 15, 2024 | marketbeat.comNuvation Bio (NYSE:NUVB) Trading 6.1% Higher Nuvation Bio (NYSE:NUVB) Shares Up 6.1%May 15, 2024 | marketbeat.comNuvation Bio's (NUVB) "Outperform" Rating Reaffirmed at WedbushWedbush reaffirmed an "outperform" rating and set a $5.00 price target on shares of Nuvation Bio in a research report on Wednesday.May 14, 2024 | msn.comNUVB Stock Earnings: Nuvation Bio Beats EPS for Q1 2024May 14, 2024 | finance.yahoo.comNuvation Bio Reports First Quarter 2024 Financial Results and Provides Business UpdateMay 3, 2024 | investing.comNuvation Bio Inc (NUVB)April 29, 2024 | marketbeat.comNuvation Bio (NYSE:NUVB) Shares Gap Up to $2.68Nuvation Bio (NYSE:NUVB) Shares Gap Up to $2.68April 24, 2024 | businesswire.comNuvation Bio to Present Updated Data on Taletrectinib, a ROS1 inhibitor, at the 2024 American Society of Clinical Oncology (ASCO) Annual MeetingApril 19, 2024 | marketbeat.comNuvation Bio (NYSE:NUVB) Stock Price Up 5%Nuvation Bio (NYSE:NUVB) Shares Up 5%April 17, 2024 | benzinga.comNuvation Bio Stock (NYSE:NUVB), Analyst Ratings, Price Targets, PredictionsApril 17, 2024 | marketbeat.comNuvation Bio (NYSE:NUVB) Price Target Raised to $5.00 at Royal Bank of CanadaRoyal Bank of Canada boosted their target price on Nuvation Bio from $4.00 to $5.00 and gave the stock an "outperform" rating in a research report on Wednesday.April 17, 2024 | marketbeat.comNuvation Bio (NYSE:NUVB) Shares Gap Up After Analyst UpgradeNuvation Bio (NYSE:NUVB) Shares Gap Up After Analyst UpgradeApril 13, 2024 | markets.businessinsider.comStrategic Acquisition Bolsters Nuvation Bio’s Growth Potential and Pipeline ProspectsApril 11, 2024 | marketbeat.comNuvation Bio (NYSE:NUVB) Trading 3.9% Higher Nuvation Bio (NYSE:NUVB) Trading Up 3.9%April 10, 2024 | marketbeat.comNuvation Bio (NYSE:NUVB) Trading Down 8.4%Nuvation Bio (NYSE:NUVB) Shares Down 8.4%April 10, 2024 | businesswire.comNuvation Bio Completes Acquisition of AnHeart TherapeuticsApril 6, 2024 | marketbeat.comAssenagon Asset Management S.A. Has $1.12 Million Position in Nuvation Bio Inc. (NYSE:NUVB)Assenagon Asset Management S.A. raised its position in Nuvation Bio Inc. (NYSE:NUVB - Free Report) by 219.3% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 738,831 shares of the company's stock after purchasing an additional 507,452April 2, 2024 | marketbeat.comNuvation Bio (NYSE:NUVB) Shares Down 6.5% Nuvation Bio (NYSE:NUVB) Shares Down 6.5%March 31, 2024 | seekingalpha.comWeek In Review: AriBio Sells China Rights To Alzheimer's Candidate In $770M DealMarch 28, 2024 | marketbeat.comNuvation Bio (NYSE:NUVB) Sees Unusually-High Trading Volume Following Analyst UpgradeNuvation Bio (NYSE:NUVB) Sees Large Volume Increase on Analyst UpgradeMarch 28, 2024 | marketbeat.comNuvation Bio (NYSE:NUVB) PT Raised to $8.00 at HC WainwrightHC Wainwright raised their price target on shares of Nuvation Bio from $5.00 to $8.00 and gave the stock a "buy" rating in a research note on Thursday.March 28, 2024 | marketbeat.comQ2 2024 EPS Estimates for Nuvation Bio Inc. Increased by Wedbush (NYSE:NUVB)Nuvation Bio Inc. (NYSE:NUVB - Free Report) - Investment analysts at Wedbush lifted their Q2 2024 earnings estimates for shares of Nuvation Bio in a report issued on Monday, March 25th. Wedbush analyst D. Nierengarten now expects that the company will post earnings per share of ($0.05) for the quMarch 28, 2024 | businesswire.comNuvation Bio Announces Appointment of Colleen Sjogren as Chief Commercial OfficerMarch 27, 2024 | marketbeat.comNuvation Bio (NYSE:NUVB) Shares Gap Up to $2.88Nuvation Bio (NYSE:NUVB) Shares Gap Up to $2.88March 27, 2024 | msn.comBTIG upgrades Nuvation to buy, cites AnHeart acquisitionMarch 27, 2024 | msn.comNuvation Bio continues to surge as more upgrades follow after AnHeart dealMarch 27, 2024 | marketbeat.comNuvation Bio (NYSE:NUVB) Upgraded at Jefferies Financial GroupJefferies Financial Group raised shares of Nuvation Bio from a "hold" rating to a "buy" rating and boosted their target price for the stock from $1.40 to $10.00 in a research report on Wednesday.March 26, 2024 | marketbeat.comNuvation Bio (NYSE:NUVB) Reaches New 12-Month High at $2.65Nuvation Bio (NYSE:NUVB) Sets New 1-Year High at $2.65March 26, 2024 | marketbeat.comBTIG Research Upgrades Nuvation Bio (NYSE:NUVB) to BuyBTIG Research raised shares of Nuvation Bio from a "neutral" rating to a "buy" rating and set a $5.00 price objective on the stock in a research report on Tuesday.March 25, 2024 | marketbeat.comNuvation Bio (NYSE:NUVB) Shares Gap Down to $2.31Nuvation Bio (NYSE:NUVB) Shares Gap Down to $2.31March 22, 2024 | marketbeat.comNuvation Bio (NYSE:NUVB) Shares Up 5.1%Nuvation Bio (NYSE:NUVB) Trading Up 5.1%March 20, 2024 | finance.yahoo.comNUVB Apr 2024 2.000 putMarch 16, 2024 | finance.yahoo.comNUVB Apr 2024 0.500 callMarch 15, 2024 | msn.comNuvation Bio begins subject dosing in Phase I/II solid tumour trialMarch 14, 2024 | businesswire.comNuvation Bio Doses First Patient in Phase 1/2 Study of NUV-1511 for the Treatment of Advanced Solid TumorsMarch 14, 2024 | baystreet.caBiotech Sector Advances in Pancreatic Cancer ResearchMarch 11, 2024 | marketbeat.comNuvation Bio Inc. Expected to Earn Q1 2024 Earnings of ($0.09) Per Share (NYSE:NUVB)Nuvation Bio Inc. (NYSE:NUVB - Free Report) - Equities researchers at HC Wainwright boosted their Q1 2024 earnings per share (EPS) estimates for shares of Nuvation Bio in a report released on Thursday, March 7th. HC Wainwright analyst R. Burns now anticipates that the company will post earnings oMarch 7, 2024 | marketbeat.comNuvation Bio (NYSE:NUVB) Reaches New 12-Month High After Analyst UpgradeNuvation Bio (NYSE:NUVB) Reaches New 52-Week High on Analyst UpgradeMarch 7, 2024 | marketbeat.comHC Wainwright Increases Nuvation Bio (NYSE:NUVB) Price Target to $5.00HC Wainwright boosted their target price on shares of Nuvation Bio from $4.50 to $5.00 and gave the stock a "buy" rating in a research report on Thursday.March 1, 2024 | marketbeat.comNuvation Bio (NYSE:NUVB) Reaches New 52-Week High at $2.34Nuvation Bio (NYSE:NUVB) Hits New 12-Month High at $2.34March 1, 2024 | marketbeat.comNuvation Bio (NYSE:NUVB) Given "Outperform" Rating at WedbushWedbush reaffirmed an "outperform" rating and issued a $5.00 price objective on shares of Nuvation Bio in a research note on Friday.March 1, 2024 | markets.businessinsider.comBuy Rating Affirmed for Nuvation Bio Amid Strong Financial Performance and Promising Clinical ProgressFebruary 29, 2024 | finance.yahoo.comNuvation Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business UpdateFebruary 29, 2024 | businesswire.comNuvation Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business UpdateFebruary 17, 2024 | finance.yahoo.comOwning 46% shares,institutional owners seem interested in Nuvation Bio Inc. (NYSE:NUVB),January 8, 2024 | msn.comFDA clears Nuvation to begin Phase 1/2 study for oncology drugJanuary 8, 2024 | finance.yahoo.comNuvation Bio Announces FDA Clearance of Investigational New Drug Application for NUV-1511 for the Treatment of Advanced Solid Tumors Get Nuvation Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for NUVB and its competitors with MarketBeat's FREE daily newsletter. Email Address The Overlooked Retirement Asset You Probably Don’t Own (Ad)4 out of 5 Americans believe we’re on the brink of a retirement crisis. Luckily, in these unprecedented times, we have an unprecedented solution. Once considered a “fringe” investment, the crypto market is now taking the world by storm. Click here to access the Crypto Retirement Blueprint now. NUVB Media Mentions By Week NUVB Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NUVB News Sentiment▼0.620.42▲Average Medical News Sentiment NUVB News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NUVB Articles This Week▼121▲NUVB Articles Average Week Get Nuvation Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for NUVB and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Sage Therapeutics News Wave Life Sciences News Nurix Therapeutics News Phibro Animal Health News Cogent Biosciences News Aurinia Pharmaceuticals News PureTech Health News CureVac News AnaptysBio News GH Research News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:NUVB) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersBuy this small stock before coming AI Tidal WaveChaikin AnalyticsCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingShocking $16T Elon Musk Crypto LeakCrypto 101 MediaForget Bitcoin: This $8 Stock Is the Next Big ThingBehind the MarketsDems have chosen Biden replacement?Paradigm PressHow Biden has already won 2024Porter & CompanyExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersA letter is coming from the "Bureau of the Fiscal Service".Stansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nuvation Bio Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
